Service agreement for 7900HT sequencer
Ended Awarded
- Contract number
- HHSN26100076
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,194
Award facts
- Contract value 100% obligated
- $7,193.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Life Technologies Corporation, doing business as Thermo Fisher Scientific, received a firm fixed-price Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on January 3, 2017, for a service agreement supporting a 7900HT sequencer. The contract, valued at $7,193.92 with an ultimate completion date of January 15, 2018, was awarded without a set-aside designation. Performance will be conducted at the NCI's facility in Bethesda, Maryland. This award represents a task order under an existing BPA vehicle, enabling streamlined procurement of specialized laboratory services and maintenance support for genetic sequencing equipment critical to NCI's cancer research operations.
The National Cancer Institute, as part of the National Institutes of Health, leverages partnerships with leading scientific equipment providers to maintain and support advanced instrumentation essential to its research mission. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, is a premier supplier of biotechnology products and scientific instruments to federal agencies. The company's expertise in providing maintenance, technical support, and specialized services for sequencing and genetic analysis platforms aligns directly with NCI's requirements for sustained operational capability of its laboratory infrastructure supporting cancer research initiatives.
Quick answers
Who was awarded contract HHSN26100076?
HHSN26100076 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on January 3, 2017.
How much is contract HHSN26100076 worth?
The government has obligated $7,194 on HHSN26100076.
Is contract HHSN26100076 an order under another contract?
Yes. HHSN26100076 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract HHSN26100076 competed?
The extent of competition for HHSN26100076 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award